Havekes LM - Search Results

1

Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatin.

Kleemann R, Princen HM, Emeis JJ, Jukema JW, Fontijn RD, Horrevoets AJ, Kooistra T, Havekes LM. Kleemann R, et al. Among authors: havekes lm. Circulation. 2003 Sep 16;108(11):1368-74. doi: 10.1161/01.CIR.0000086460.55494.AF. Epub 2003 Aug 25. Circulation. 2003. PMID: 12939225

2

Anti-atherosclerotic effect of amlodipine, alone and in combination with atorvastatin, in APOE*3-Leiden/hCRP transgenic mice.

Trion A, de Maat M, Jukema W, Maas A, Offerman E, Havekes L, Szalai A, van der Laarse A, Princen H, Emeis J. Trion A, et al. J Cardiovasc Pharmacol. 2006 Jan;47(1):89-95. doi: 10.1097/01.fjc.0000195603.65858.27. J Cardiovasc Pharmacol. 2006. PMID: 16424791

3

Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE*3Leiden.CETP transgenic mice with or without treatment with atorvastatin.

Kühnast S, van der Hoorn JW, van den Hoek AM, Havekes LM, Liau G, Jukema JW, Princen HM. Kühnast S, et al. Among authors: havekes lm. J Hypertens. 2012 Jan;30(1):107-16. doi: 10.1097/HJH.0b013e32834ddd8e. J Hypertens. 2012. PMID: 22134386

4

Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol.

Kühnast S, Louwe MC, Heemskerk MM, Pieterman EJ, van Klinken JB, van den Berg SA, Smit JW, Havekes LM, Rensen PC, van der Hoorn JW, Princen HM, Jukema JW. Kühnast S, et al. Among authors: havekes lm. PLoS One. 2013 Jun 19;8(6):e66467. doi: 10.1371/journal.pone.0066467. Print 2013. PLoS One. 2013. PMID: 23840481 Free PMC article.

5

Raman spectroscopic investigation of atorvastatin, amlodipine, and both on atherosclerotic plaque development in APOE*3 Leiden transgenic mice.

van de Poll SW, Delsing DJ, Jukema JW, Princen HM, Havekes LM, Puppels GJ, van der Laarse A. van de Poll SW, et al. Among authors: havekes lm. Atherosclerosis. 2002 Sep;164(1):65-71. doi: 10.1016/s0021-9150(02)00055-2. Atherosclerosis. 2002. PMID: 12119194

6

Differential effects of amlodipine and atorvastatin treatment and their combination on atherosclerosis in ApoE*3-Leiden transgenic mice.

Delsing DJ, Jukema JW, van de Wiel MA, Emeis JJ, van der Laarse A, Havekes LM, Princen HM. Delsing DJ, et al. Among authors: havekes lm. J Cardiovasc Pharmacol. 2003 Jul;42(1):63-70. doi: 10.1097/00005344-200307000-00010. J Cardiovasc Pharmacol. 2003. PMID: 12827028

7

Hepatic low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol.

Espirito Santo SM, Pires NM, Boesten LS, Gerritsen G, Bovenschen N, van Dijk KW, Jukema JW, Princen HM, Bensadoun A, Li WP, Herz J, Havekes LM, van Vlijmen BJ. Espirito Santo SM, et al. Among authors: havekes lm. Blood. 2004 May 15;103(10):3777-82. doi: 10.1182/blood-2003-11-4051. Epub 2004 Jan 22. Blood. 2004. PMID: 14739216 Free article.

8

Well-characterized garlic-derived materials are not hypolipidemic in APOE*3-Leiden transgenic mice.

Espirito Santo SM, van Vlijmen BJ, Buytenhek R, van Duyvenvoorde W, Havekes LM, Arnault I, Auger J, Princen HM. Espirito Santo SM, et al. Among authors: havekes lm. J Nutr. 2004 Jun;134(6):1500-3. doi: 10.1093/jn/134.6.1500. J Nutr. 2004. PMID: 15173418 Free article.

9

Absence of an atheroprotective effect of the garlic powder printanor in APOE*3-Leiden transgenic mice.

Espirito Santo SM, van Vlijmen BJ, van Duyvenvoorde W, Offerman EH, Havekes LM, Arnault I, Auger J, Princen HM. Espirito Santo SM, et al. Among authors: havekes lm. Atherosclerosis. 2004 Dec;177(2):291-7. doi: 10.1016/j.atherosclerosis.2004.07.024. Atherosclerosis. 2004. PMID: 15530902

10

Rosuvastatin reduces plasma lipids by inhibiting VLDL production and enhancing hepatobiliary lipid excretion in ApoE*3-leiden mice.

Delsing DJ, Post SM, Groenendijk M, Solaas K, van der Boom H, van Duyvenvoorde W, de Wit EC, Bloks VW, Kuipers F, Havekes LM, Princen HM. Delsing DJ, et al. Among authors: havekes lm. J Cardiovasc Pharmacol. 2005 Jan;45(1):53-60. doi: 10.1097/00005344-200501000-00010. J Cardiovasc Pharmacol. 2005. PMID: 15613980

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

448 results

Search Page

Filters